We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+10.89%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$14.8B
AUM Growth
+$1.41B
Cap. Flow
-$396M
Cap. Flow %
-2.67%
Top 10 Hldgs %
34.28%
Holding
1,311
New
31
Increased
615
Reduced
268
Closed
37

Top Buys

Rank Stock Value
1
AVB icon
AvalonBay Communities
AVB
+$175M
2
EQIX icon
Equinix
EQIX
+$158M
3
AMT icon
American Tower
AMT
+$91.5M
4
KIM icon
Kimco Realty
KIM
+$76.2M
5
SOCL icon
Global X Social Media ETF
SOCL
+$43.2M

Top Sells

Rank Stock Value
1
INVH icon
Invitation Homes
INVH
+$172M
2
MAA icon
Mid-America Apartment Communities
MAA
+$148M
3
MPT
Medical Properties Trust
MPT
+$126M
4
VICI icon
VICI Properties
VICI
+$115M
5
DLR icon
Digital Realty Trust
DLR
+$97.3M

Sector Composition

Rank Sector Weight
1 Real Estate 59.19%
2 Technology 7.88%
3 Communication Services 4.43%
4 Consumer Discretionary 3.51%
5 Financials 3.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XENE icon
1201
Xenon Pharmaceuticals
XENE
$6.33B
$1K ﹤0.01%
66
– –
QTTB icon
1202
Q32 Bio
QTTB
$458M
$1K ﹤0.01%
6
– –
TECX
1203
Tectonic Therapeutic
TECX
$576M
$1K ﹤0.01%
7
– –
TVRD
1204
Tvardi Therapeutics
TVRD
$24.6M
$1K ﹤0.01%
3
– –
SYRS
1205
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$1K ﹤0.01%
10
– –
PSTX
1206
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$1K ﹤0.01%
116
– –
EGRX
1207
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$1K ﹤0.01%
30
– –
FUSN
1208
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$1K ﹤0.01%
78
– –
MRNS
1209
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$1K ﹤0.01%
58
– –
EIGR
1210
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$1K ﹤0.01%
2
– –
GMDA
1211
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$1K ﹤0.01%
93
– –
CBAY
1212
DELISTED
Cymabay Therapeutics
CBAY
$1K ﹤0.01%
152
– –
BCEL
1213
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$1K ﹤0.01%
65
– –
ORTX
1214
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$1K ﹤0.01%
13
– –
ICPT
1215
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$1K ﹤0.01%
62
– –
PRTK
1216
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$1K ﹤0.01%
86
– –
SURF
1217
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$1K ﹤0.01%
77
– –
HARP
1218
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$1K ﹤0.01%
5
– –
KDNY
1219
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$1K ﹤0.01%
79
– –
SPPI
1220
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$1K ﹤0.01%
321
– –
ISEE
1221
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$1K ﹤0.01%
168
– –
TCRR
1222
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$1K ﹤0.01%
63
– –
JNCE
1223
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$1K ﹤0.01%
75
– –
PRVB
1224
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$1K ﹤0.01%
106
– –
ATNX
1225
DELISTED
Athenex, Inc. Common Stock
ATNX
$1K ﹤0.01%
9
– –
47 48
49
50 51

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q2 2021 Portfolio in Review

As of Q2 2021, Daiwa Securities Group held 1,311 positions worth $14.8B, up 10% from $13.4B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Daiwa Securities Group's Q2 2021 filing shows 31 new, 615 increased, 268 reduced and 37 closed positions. Its largest new stake was Algonquin Power & Utilities Corp Units: 325,000 shares worth $16.1M. The largest sale was Invitation Homes, an estimated $172M.

By sector, the portfolio is most concentrated in Real Estate at 59% of assets, down from 61% a quarter earlier, followed by Technology and Communication Services.

  • Daiwa Securities Group's largest Q2 2021 buy was Algonquin Power & Utilities Corp Units: 325,000 shares worth $16.1M.
  • Daiwa Securities Group added most to AvalonBay Communities in Q2 2021, an estimated $175M increase.
  • Daiwa Securities Group's biggest Q2 2021 reduction was Invitation Homes, cutting an estimated $172M.
  • Daiwa Securities Group fully exited Global X Cloud Computing ETF in Q2 2021, selling an estimated $29.5M.
  • Daiwa Securities Group's ten largest holdings make up 34% of its $14.8B portfolio in Q2 2021.
  • Daiwa Securities Group opened 31 new positions and closed 37 in Q2 2021.
  • Daiwa Securities Group's portfolio value rose 10% quarter-over-quarter to $14.8B.

Based on Daiwa Securities Group's 13F filing for Q2 2021, filed 6 Aug 2021.